Hyperthyroidism and heart failure

Authors

  • Sonia Dayana Riveros Bermudez Especialización en Medicina Interna, Grupo Interinstitucional de Medicina Interna (GIMI1), Facultad de Ciencias de la Salud, Universidad Libre Seccional Cali, Colombia https://orcid.org/0000-0002-6194-0413
  • María Elena Pantoja Rosero Especialización en Medicina Interna, Grupo Interinstitucional de Medicina Interna (GIMI1), Facultad de Ciencias de la Salud, Universidad Libre Seccional Cali, Colombia; https://orcid.org/0000-0003-4081-2559
  • Alin Abreu Lomba Clinica Imbanaco, Cali, Colombia; Especialización Medicina Interna, Grupo Interinstitucional de Medicina Interna (GIMI1), Universidad Libre Seccional Cali, Colombia https://orcid.org/0000-0002-7377-4969

DOI:

https://doi.org/10.18041/2665-427X/ijeph.1.10271

Keywords:

hyperthyroidism, heart failure, hyroid hormones, pathophysiological mechanisms , heart, dilated cardiomyopathy

Abstract

Introduction: Hyperthyroidism is characterized by an increase in the synthesis of thyroid hormones, which have an important effect on the cardiovascular system, which could predispose to the development of heart failure in this population.

Objective: To review the pathophysiological mechanisms through which heart failure occurs in patients with hyperthyroidism.

Methods: A narrative review of the literature on the effect of hyperthyroidism on the heart and the pathophysiological mechanisms related to heart failure was performed.

Results: Increased thyroid hormones exert an effect on heart rate, contractile function, and electrical conduction of the heart, which is related to the appearance of high output heart failure and late the presence of dilated cardiomyopathy can be observed, findings potentially reversible with the treatment of the underlying pathology.
Conclusions: Hyperthyroidism-related heart failure is a heterogeneous disease, potentially reversible with treatment of the underlying endocrinological disease.

Downloads

Download data is not yet available.

References

Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nature Rev Endocrinol. 2018; 14(5): 301-316. Doi: 10.1038/nrendo.2018.18.

Li H, Zeng R, Liao Y, Fu M, Zhang H, Wang L, et al. Prevalence and risk factors of left ventricular diastolic dysfunction in patients with hyperthyroidism. Frontiers Endocrinol. 2021; 11: 605712. Doi: 10.3389/fendo.2020.605712

Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the heart. Methodist DeBakey Cardiovasc J. 2017; 13(2): 60-63. Doi: 10.14797/mdcj-13-2-60

Razvi S, Jabbar A, Pingitore A, Danzi S, Biondi B, Klein I, et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol. 2018; 71(16): 1781-96. Doi: 10.1016/j.jacc.2018.02.045

Klein I, Danzi S. Thyroid Disease and the heart. Circulation. 2007; 116(15): 1725-35. Doi: 10.1161/CIRCULATIONAHA.106.678326

Vargas F, Moreno JM, Rodríguez-Gómez I, Wangensteen R, Osuna A, Alvarez-Guerra M, et al. Vascular and renal function in experimental thyroid disorders. Europ J Endocrinol. 2006; 154(2): 197-212. Doi: 10.1530/eje.1.02093

Yamakawa H, Kato TS, Noh JY, Yuasa S, Kawamura A, Fukuda K, et al. Thyroid hormone plays an important role in cardiac function: from bench to bedside. Frontiers Physiol. 2021; 12: 606931. Doi: 10.3389/fphys.2021.606931

Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocrine Rev. 2005; 26(5): 704-728. Doi: 10.1210/er.2003-0033

Vargas-Uricoechea H, Sierra-Torres CH. Thyroid hormones and the heart. Hormone Mol Biol Clin investig. 2014; 18(1): 15-26. Doi: 10.1515/hmbci-2013-0059

Naser JA, Pislaru S, Stan MN, Lin G. Incidence, risk factors, natural history and outcomes of heart failure in patients with Graves' disease. Heart. 2022; 108(11): 868-874. Doi: 10.1136/heartjnl-2021-319752

Espinosa deYAE. Mujer, corazón y tiroides. Rev Colomb Cardiol. 2018; 25(S1): 42-48. Doi: 10.1016/j.rccar.2017.12.001

Martinez F. Thyroid hormones and heart failure. Heart Failure Rev. 2016; 21(4): 361-364. Doi: 10.1007/s10741-016-9556-5

Selmer C, Olesen JB, Hansen ML, von Kappelgaard LM, Madsen JC, Hansen PR, et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metabol. 2014; 99(7): 2372-2382. Doi: 10.1210/jc.2013-4184

Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012; 345: e7895. Doi: 10.1136/bmj.e7895

Yue WS, Chong BH, Zhang XH, Liao SY, Jim MH, Kung AW, et al. Hyperthyroidism-induced left ventricular diastolic dysfunction: implication in hyperthyroidism-related heart failure. Clinical Endocrinol. 2011; 74(5): 636-643. Doi: 10.1111/j.1365-2265.2011.03981.x

Muthukumar S, Sadacharan D, Ravikumar K, Mohanapriya G, Hussain Z, Suresh RV. A prospective study on cardiovascular dysfunction in patients with hyperthyroidism and its reversal after surgical cure. World J Surg. 2016; 40(3): 622-628. Doi: 10.1007/s00268-015-3352-6.

Published

2023-06-30 — Updated on 2024-05-08

Versions

Issue

Section

Endocrinology symposia

How to Cite

Hyperthyroidism and heart failure. (2024). Interdisciplinary Journal of Epidemiology and Public Health, 6(1), e-10271. https://doi.org/10.18041/2665-427X/ijeph.1.10271 (Original work published 2023)

Most read articles by the same author(s)